{"cik":1054102,"taxonomy":"us-gaap","tag":"DeferredIncomeTaxAssetsNet","label":"Deferred Income Tax Assets, Net","description":"Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.","entityName":"Interpace Biosciences, Inc.","units":{"USD":[{"end":"2025-12-31","val":21254000,"accn":"0001493152-26-013646","fy":2025,"fp":"FY","form":"10-K","filed":"2026-03-30"},{"end":"2025-12-31","val":21254000,"accn":"0001493152-26-022508","fy":2026,"fp":"Q1","form":"10-Q","filed":"2026-05-12","frame":"CY2025Q4I"},{"end":"2026-03-31","val":20977000,"accn":"0001493152-26-022508","fy":2026,"fp":"Q1","form":"10-Q","filed":"2026-05-12","frame":"CY2026Q1I"}]}}